Signals One™
Make your innovations a reality with the first unified, cloud-native SaaS R&D solution that streamlines scientific complexity and promotes collaboration.
Signals One™
Receive your quote directly from the manufacturer.
Signals One™ is an end-to-end R&D workflow solution providing data capture & collaboration, data processing, and data-driven analytics.
Signals One is ideally suited to handle research use cases involving earlier stage in-vitro assays, later stage in-vitro assays, cell line optimization, biologics process optimization, in vitro DMPK assays, animal pharmacokinetic studies, stage animal efficacy and safety studies.
Benefits:
- Signals One implements 24/7 global security monitoring, alerting, and escalation by the Revvity Signals Software Security Operations Center.
- Signals One accelerates the drug discovery process for these novel therapeutics by providing tools for assay development, hit identification, and lead optimization.
- Signals One is a fully integrated platform that encapsulates trusted products, avoiding the complexities and inefficiencies of a piecemeal, application-centric ecosystem.
Brochures
Revvity Signals One, an intelligent R&D data management software solution
Revvity Signals One is a cloud-based R&D data management solution designed to help chemicals and materials science organizations streamline research, formulation, and product development workflows. Combining Signals™ Notebook, ChemDraw, and Spotfire technologies, the platform centralizes experimental data, digitizes laboratory processes, and enables advanced analysis and visualization within a single environment.
By replacing fragmented spreadsheets and siloed data systems with a structured, collaborative workflow, Signals One™ helps researchers accelerate decision-making, improve product performance, and reduce development timelines. The platform supports formulation optimization, regulatory compliance, inventory management, and AI-ready analytics, enabling teams to bring innovative products to market more efficiently.
Resource details:
- Resource type: Product brochure
- Page count: 12
- Read time: 18 mins
An intelligent R&D data management software solution
This brochure introduces Signals One, an integrated data management platform designed to streamline R&D and formulation workflows in chemistry-driven industries. By unifying experimental data, analytics, and collaboration tools in a cloud-based environment, the platform helps address common challenges associated with fragmented data systems and manual processes. Signals One combines electronic lab notebook capabilities with advanced data visualization and modelling tools to support experiment planning, data analysis, and regulatory compliance. The solution enables faster decision making, reduces development timelines, and improves productivity in the development of new chemical products and formulations.
Signals One for new biological and chemical modalities research
Explore Signals One™, a unified, cloud‑native SaaS platform designed to support drug discovery research across emerging biological and chemical modalities. Signals One brings together design, experimentation, data capture, analytics, and decision‑making within a single workflow‑focused environment, helping scientists manage the complexity of modern R&D.
Discover how the platform integrates tools such as ChemDraw®, HELM notation for biomolecules, native and Spotfire‑powered analytics, and AI‑ready data infrastructure to enable collaboration across multidisciplinary teams. By connecting chemical and biological data throughout the Design‑Make‑Test‑Decide lifecycle, Signals One helps organizations reduce data silos, improve insight generation, and accelerate the progression of new therapeutic candidates.
Mastering multimodal drug discovery
Modern drug discovery is becoming increasingly multimodal. Alongside traditional small molecules, researchers are advancing protein degraders, antibody-drug conjugates, RNA therapeutics, and cell and gene therapies, each generating unique datasets across chemistry, biology, and translational research. While these modalities offer exciting therapeutic opportunities, they also create new challenges around data management, collaboration, and decision-making.
Many organizations continue to rely on disconnected informatics systems that were built to support individual workflows rather than integrated discovery. As data becomes increasingly fragmented across teams and technologies, it can be difficult to connect insights, revisit historical results, and fully leverage emerging AI and machine learning approaches. Building unified, AI-ready research environments is becoming critical for accelerating discovery while maintaining scientific rigor.
This SelectScience guide, developed in partnership with Revvity Signals, explores how connected informatics ecosystems can help streamline multimodal drug discovery workflows. Through expert perspectives, real-world examples, and practical insights, discover how organizations are breaking down data silos, supporting collaboration across disciplines, and enabling more efficient progression through the design-make-test-decide (DMTA) cycle.
Download this SelectScience guide to explore:
- The operational challenges facing modern multimodal drug discovery
- Why emerging therapeutic modalities demand integrated informatics strategies
- How workflow fragmentation slows research and decision-making
- Approaches for standardizing discovery with unified digital ecosystems
- Strategies for connecting molecular biology and therapeutic design workflows
- Supporting protein degraders, antibodies, RNA therapeutics, and other emerging modalities
- How structured, AI-ready data can help accelerate discovery programs
Resource details:
- Document type: SelectScience guide
- Page count: 50
- Read time: 90 mins
- Edition: 1st
Empowering modern research with electronic lab notebooks
This eBook explores how electronic lab notebooks (ELNs) are transforming modern research by improving data management, collaboration, and reproducibility. It highlights the shift from paper-based workflows to integrated digital platforms that connect experimental design, data capture, and analysis across teams. Featuring Signals™ Notebook, the eBook demonstrates how cloud-based ELNs can unify chemical and biological data, streamline documentation, and support decision-making throughout the drug discovery process.
Discover how by enabling structured data capture, real-time collaboration, and scalable workflows, ELNs help reduce inefficiencies, accelerate research timelines, and support more reliable and compliant scientific outcomes.
Building a unified design-make-test-decide approach to drug discovery
This resource explores how integrated digital platforms can improve efficiency and decision-making in modern drug discovery workflows. It highlights the transition from traditional design‑make‑test‑analyze cycles to a more dynamic design‑make‑test‑decide approach, enabling real-time insights across multidisciplinary teams.
The Signals One™ platform brings together molecule design, assay data, analytics, and experiment tracking in a unified environment, helping researchers connect data across workflows and reduce inefficiencies caused by fragmented systems. Discover how by supporting collaboration and providing actionable insights, the approach aims to accelerate candidate selection and improve outcomes in complex therapeutic development.
Building stronger AI foundations for drug discovery
This resource explores how the success of artificial intelligence in drug discovery depends on the quality, structure, and governance of underlying data. It highlights how fragmented, incomplete, or biased datasets can limit AI performance, and outlines approaches to improve data readiness through FAIR principles, standardization, and collaborative frameworks such as federated learning.
Explore how platforms like Signals One™ enable researchers to unify and structure data across workflows, supporting more reliable AI‑driven insights and accelerating decision‑making in drug development.
Transforming formulation science with the innovation of Signals One
July 24, 2025, 16:00 BST / 17:00 CEST / 11:00 EDT / 8:00 PDT
In today’s fast-paced formulation science landscape, the ability to seamlessly capture, manage, and share experimental data is a critical driver of innovation. Equipping researchers with secure and accurate software, accelerates workflows and unlocks the full potential of every experiment.
Join Revvity Signals experts, Marie Jué, Sr. Field Application Scientist and Jun Liu, Senior Marketing Manager, as they deep dive into a software that streamlines formulation workflows in R&D. Discover how the Signals One™ platform can reduce reliance on spreadsheets, minimize errors, and accelerate decision-making with built-in scientific intelligence.
Plus, hear real-world stories of how scientists have utilized this platform to capture, analyze, and visualize formulation data with greater accuracy and speed to drive their research forward.
Certificate of attendance
If you attend the live webinar, you will automatically receive a certificate of attendance, including a learning outcomes summary, for continuing education purposes.
If you view the on-demand webinar, you can request a certificate of attendance by emailing editor@selectscience.net.
Webinar details
- Cost: Free to attend
- Location: Online
- Duration: 60 minutes
Registration is required to secure your place. If you register but can’t attend live, you will receive a link to the on‑demand recording once it becomes available.
TechTalk: Transforming formulation science with Signals One Software
Friday, June 12 at 15:00 BST | 16:00 CEST | 10:00 EDT | 7:00 PDT
Modern formulation development demands more than spreadsheets. It requires intelligent software that unifies data management, chemistry intelligence, and advanced analytics. This SelectScience® TechTalk demonstrates how Signals One addresses the escalating complexity of formulation science, where dozens of input factors, non-linear relationships, and regulatory/sustainability constraints generate massive experimental datasets requiring sophisticated analysis.
Attendees will discover how this platform combines powerful formulation table management with project coordination, material library integration, automated instrument data capture, and chemistry-aware capabilities through embedded ChemDraw functionality.
Whether you are in coatings, polymers, or cosmetics, this TechTalk will reveal how Signals One accelerates R&D cycles by transforming dispersed data into actionable insights helping teams make faster, data-driven decisions while maintaining complete traceability from formulation design through scale-up.
Certificate of attendance
If you attend the live TechTalk, you will automatically receive a certificate of attendance, including a learning outcomes summary, for continuing education purposes.
If you view the on-demand TechTalk, you can request a certificate of attendance by emailing editor@selectscience.net.
TechTalk details
- Cost: Free to attend
- Location: Online
- Duration: 20 minutes
Registration is required to secure your place. If you register but can’t attend live, you will receive a link to the on‑demand recording once it becomes available.
How smarter data management and machine‑learning‑driven design of experiments accelerate formulation development
Monday, June 29 at 16:00 BST | 17:00 CEST | 11:00 EDT | 8:00 PDT
Formulation development is becoming increasingly complex, and traditional spreadsheet‑based approaches often struggle to keep up with multidimensional ingredient interactions and growing sustainability demands. Today’s R&D teams need modern, data‑driven technologies that simplify experimentation and speed up decision‑making.
In this SelectScience® webinar join Dr. Tom Whiteheads, Head of Machine learning at Intellegens and Jun Liu from Revvity Signals to discover how emerging digital and machine‑learning approaches can cut experimental workload by 50–80% while accelerating insight generation. Dr. Whiteheads and Liu will introduce a new technological pathway for formulation science built around unified digital workflows and Adaptive Experimental Design (AED), a machine learning–driven method for navigating complex formulation spaces.
You will explore how to bring together formulation data management, material libraries, automated data capture, and chemistry‑aware tools such as embedded ChemDraw, while using AED to iteratively optimize formulations and processes. Together, the speakers will highlight how these capabilities help accelerate R&D, turn fragmented data into actionable insights, and support faster, more efficient, and more sustainable formulation development.
Certificate of attendance
If you attend the live webinar, you will automatically receive a certificate of attendance, including a learning outcomes summary, for continuing education purposes.
If you view the on-demand webinar, you can request a certificate of attendance by emailing editor@selectscience.net.
Webinar details
- Cost: Free to attend
- Location: Online
- Duration: 60 minutes per session
Registration is required to secure your place. If you register but can’t attend live, you will receive a link to the on‑demand recording once it becomes available
Navigating the new era of GxP compliance with smarter digital workflows
Tuesday, June 16 at 16:00 BST | 17:00 CEST | 11:00 EDT | 08:00 PDT
Pharmaceutical and biopharmaceutical teams working in GxP‑regulated environments are navigating growing regulatory demands, legacy system limitations, and the need to modernize digital workflows while maintaining strict compliance with global standards such as 21 CFR Part 11, Annex 11, and broader GxP frameworks. As these pressures intensify, many organizations are seeking clearer strategies and proven approaches to evolve their systems without introducing compliance risk.
In this SelectScience® webinar, GxP experts Ankita Dhar and Jenny Lesinski from Revvity Signals will share practical strategies for streamlining compliant workflows, strengthening data integrity, and reducing the burden of computer system validation using a portfolio of solutions including Signals One™. They will also spotlight real-world stories that illustrate the challenges teams face, from managing complex validation cycles to adapting to shifting regulatory expectations, and how those organizations successfully addressed them.
Whether you are exploring new digital solutions or looking to optimize existing regulated workflows, this session will equip you with actionable insights to enhance compliance, improve efficiency, and support long-term operational excellence.
Certificate of attendance
If you attend the live webinar, you will automatically receive a certificate of attendance, including a learning outcomes summary, for continuing education purposes.
If you view the on-demand webinar, you can request a certificate of attendance by emailing editor@selectscience.net.
Webinar details
- Cost: Free to attend
- Location: Online
- Duration: 60 minutes
Registration is required to secure your place. If you register but can’t attend live, you will receive a link to the on‑demand recording once it becomes available.
Revvity introduces Signals AI, a native agentic framework to accelerate scientific R&D
Native agentic framework turns connected data and knowledge into task-ready insights for scientists
New software solutions are rewiring formulation science
From smarter data capture to predictive analysis, next‑generation R&D data platforms are streamlining complexity and accelerating decision‑making across the lab
